Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52024M11447

Prior notification of a concentration (Case M.11447 – BRIDGEPOINT / NEXITY LAMY AND ORALIA PARTENAIRES) – Candidate case for simplified procedure

PUB/2024/64

OJ C, C/2024/1353, 6.2.2024, ELI: http://data.europa.eu/eli/C/2024/1353/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/C/2024/1353/oj

European flag

Official Journal
of the European Union

EN

Series C


C/2024/1353

6.2.2024

Prior notification of a concentration

(Case M.11447 – BRIDGEPOINT / NEXITY LAMY AND ORALIA PARTENAIRES)

Candidate case for simplified procedure

(Text with EEA relevance)

(C/2024/1353)

1.   

On 26 January 2024, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

Bridgepoint Group plc (‘Bridgepoint’) of United Kingdom,

Nexity Lamy and Oralia Partenaires, wholly owned and controlled by Nexity SA, all of France.

Bridgepoint will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Nexity Lamy and Oralia Partenaires.

The concentration is accomplished by way of purchase of shares.

2.   

The business activities of the undertakings concerned are the following:

Bridgepoint is active in private asset growth investing across private equity and private debt, focusing on middle market businesses across four verticals: (i) Advanced Industrials, (ii) Business & Financial Services, (iii) Consumer and (iv) Healthcare.

Nexity Lamy and Oralia Partenaires are two wholly-owned subsidiaries of Nexity SA, operating in real estate services and real estate insurance brokerage services in France.

3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified treatment for certain concentrations under Council Regulation (EC) No 139/2004 on the control of concentrations between undertakings (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.   

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.11447 – BRIDGEPOINT / NEXITY LAMY AND ORALIA PARTENAIRES

Observations can be sent to the Commission by email or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË


(1)   OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)   OJ C 160, 5.5.2023, p. 1.


ELI: http://data.europa.eu/eli/C/2024/1353/oj

ISSN 1977-091X (electronic edition)


Top